v3.26.1
Debt - Schedule of Debt (Parenthetical) (Details)
$ in Thousands, € in Millions
6 Months Ended
Jun. 30, 2026
EUR (€)
Jun. 30, 2026
CAD ($)
Jun. 30, 2026
USD ($)
Debt Instrument [Line Items]      
Long-term Debt     $ 1,275,000,000
Senior Notes | Minimum      
Debt Instrument [Line Items]      
Senior Notes, redemption notice days 10 days    
Senior Notes | Maximum      
Debt Instrument [Line Items]      
Senior Notes, redemption notice days 60 days    
2028 Senior Notes      
Debt Instrument [Line Items]      
Debt, interest rate 12.875% 12.875% 12.875%
Debt, maturity date Oct. 01, 2028    
2029 Senior Notes      
Debt Instrument [Line Items]      
Debt, interest rate 5.125% 5.125% 5.125%
Debt, maturity date Feb. 01, 2029    
Debt Instrument, Redemption Price, Percentage 100.00%    
German Facility - EUR 370.1 Million      
Debt Instrument [Line Items]      
Debt, interest rate 5.361% 5.361% 5.361%
Line of credit, current borrowing capacity | € € 300.0    
Line of credit, maximum borrowing capacity | € € 370.1    
Debt, description of variable basis spread Euribor    
Long-term Debt € 202.0   $ 230,159,000
Debt, amount of debt supporting bank guarantees 21.4   24,414,000
Line of credit facility, remaining borrowing capacity € 76.6   $ 87,247,000
Debt instrument, covenant compliance and waiver, description As of March 31, 2026, the Company’s German subsidiaries that are borrowers under the German Facility did not meet the required leverage ratio thereunder. A waiver dated May 4, 2026, was received with respect to the leverage ratio financial covenant for the first three quarters of 2026, such that the leverage ratio financial covenant will not be required to be tested with respect to any quarter until the quarter ending December 31, 2026 (and thereafter), following the expiration of the existing waiver. Under the terms of the waiver, distributions to the parent entity are prohibited until September 30, 2026 (subject to limited exceptions). Additionally, certain covenants were modified, one of which limits facility utilization to €300.0 million while the leverage ratio exceeds 2.00:1.00. The waiver also provides for, among other things, modifications to the existing variable margin to a range of 2.50% to 4.25% depending on prescribed leverage ratios, a grant of security over certain assets, and creates additional events of default such as cross-defaults to certain of the Company’s other indebtedness, including the outstanding Senior Notes and Canadian Facility, and provides other ancillary lender protections. Management has determined it is probable that the Company will not meet the required leverage ratio with respect to the quarter ending December 31, 2026, following the expiration of the existing waiver. As a result, the amount due under the German Facility has been classified as current in the Interim Consolidated Balance Sheet. As of June 30, 2026, adjusting for the utilization limit, approximately €76.6 million ($87,247) was available for future draws. While non-compliance with the leverage ratio financial covenant addressed pursuant to the waiver did not and does not trigger any cross-default provisions under the Company’s Senior Notes or Canadian Facility, an unwaived breach with respect to the quarter ending December 31, 2026 could lead to a default and subsequent cross-defaults if the lenders under the German Facility exercise their acceleration rights.    
Debt instrument, waiver date May 04, 2026    
Debt instrument, covenant compliance waiver period 90 days    
Debt instrument waiver calculation date Dec. 31, 2026    
Debt instrument, covenant breach, description Under the terms of the waiver, distributions to the parent entity are prohibited until September 30, 2026 (subject to limited exceptions). Additionally, certain covenants were modified, one of which limits facility utilization to €300.0 million while the leverage ratio exceeds 2.00:1.00. The waiver also provides for, among other things, modifications to the existing variable margin to a range of 2.50% to 4.25% depending on prescribed leverage ratios, a grant of security over certain assets, and creates additional events of default such as cross-defaults to certain of the Company’s other indebtedness, including the outstanding Senior Notes and Canadian Facility, and provides other ancillary lender protections.    
Debt instrument, leverage ratio 2.00%    
German Facility - EUR 370.1 Million | Minimum      
Debt Instrument [Line Items]      
Debt, variable basis spread 1.40%    
Debt, waiver variable basis spread 2.50%    
German Facility - EUR 370.1 Million | Maximum      
Debt Instrument [Line Items]      
Debt, variable basis spread 2.35%    
Interest rate margin subject to upward or downward adjustments 0.05%    
Debt, waiver variable basis spread 4.25%    
Canadian Facility - C$160 Million      
Debt Instrument [Line Items]      
Debt, interest rate 4.014% 4.014% 4.014%
Line of credit, maximum borrowing capacity   $ 160,000  
Long-term Debt   121,500 $ 85,500,000
Line of credit facility, remaining borrowing capacity   19,500 13,787,000
Line of credit, letters of credit outstanding, amount   $ 600 425,000
Canadian Facility - C$160 Million | Canadian Dollar Borrowings Rate Option 2      
Debt Instrument [Line Items]      
Debt, description of variable basis spread designated prime rate    
Canadian Facility - C$160 Million | Canadian Dollar Borrowings Rate Option 1      
Debt Instrument [Line Items]      
Debt, description of variable basis spread Adjusted Term Canadian Overnight Repo Rate Average    
Canadian Facility - C$160 Million | US Dollar Borrowings Rate Option 1a      
Debt Instrument [Line Items]      
Debt, description of variable basis spread federal funds rate    
Debt, variable basis spread 0.50%    
Canadian Facility - C$160 Million | US Dollar Borrowings Rate Option 1b      
Debt Instrument [Line Items]      
Debt, description of variable basis spread Adjusted Term Secured Overnight Financing Rate (“SOFR”) for a one month tenor    
Debt, variable basis spread 1.00%    
Canadian Facility - C$160 Million | US Dollar Borrowings Rate Option 1c      
Debt Instrument [Line Items]      
Debt, description of variable basis spread bank’s applicable reference rate for dollar denominated loans    
Canadian Facility - C$160 Million | US Dollar Borrowings Rate Option 2      
Debt Instrument [Line Items]      
Debt, description of variable basis spread Adjusted Term SOFR    
Canadian Facility - C$160 Million | Minimum | Canadian Dollar Borrowings Rate Option 1      
Debt Instrument [Line Items]      
Debt, variable basis spread 1.20%    
Canadian Facility - C$160 Million | Minimum | US Dollar Borrowings Rate Option 2      
Debt Instrument [Line Items]      
Debt, variable basis spread 1.20%    
Canadian Facility - C$160 Million | Maximum | Canadian Dollar Borrowings Rate Option 1      
Debt Instrument [Line Items]      
Debt, variable basis spread 1.45%    
Canadian Facility - C$160 Million | Maximum | US Dollar Borrowings Rate Option 2      
Debt Instrument [Line Items]      
Debt, variable basis spread 1.45%    
Rosenthal Credit Facility - EUR 2.6 Million      
Debt Instrument [Line Items]      
Line of credit, maximum borrowing capacity | € € 2.6    
Debt, description of variable basis spread three-month Euribor    
Debt, variable basis spread 2.50%    
Debt, amount of debt supporting bank guarantees € 2.6   2,908,000
Line of credit facility, remaining borrowing capacity     $ 0
Standby Letters of Credit Facility C$20 Million      
Debt Instrument [Line Items]      
Debt, interest rate 0.50% 0.50% 0.50%
Line of credit, maximum borrowing capacity   $ 20,000  
Line of credit facility, remaining borrowing capacity   16,900 $ 11,874,000
Line of credit, letters of credit outstanding, amount   3,100 $ 2,200,000
Debt instrument fee amount   $ 300